NeuroSense Therapeutics Ltd. (NRSN) vs Tempest Therapeutics, Inc. (TPST)

NeuroSense Therapeutics Ltd. and Tempest Therapeutics, Inc. are both Biotechnology companies. NeuroSense Therapeutics Ltd. and Tempest Therapeutics, Inc. are of similar size ($14.4M and $14.0M). Across the 7 metrics below, NeuroSense Therapeutics Ltd. leads on 5 and Tempest Therapeutics, Inc. on 2.

Valuation

Metric NRSN TPST Biotechnology median
P/E n/m n/m 7.88
P/S n/m 39.00 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 52.83 10.73
Earnings yield (179.97%) (515.66%) (28.84%)
Free cash flow yield (339.53%) (167.50%) (23.03%)

Profitability

Metric NRSN TPST Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (931.14%) (57.72%)
Return on assets 0.00% (237.25%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRSN TPST Biotechnology median
Revenue growth (TTM) — (52.98%) 5.64%
EPS growth (last fiscal year) 20.45% 67.55% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRSN TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.71 0.38 4.73
Net debt to EBITDA 0.01 0.29 0.96

Dividend

Metric NRSN TPST Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NRSN TPST Biotechnology median
Market cap 14.04m 14.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack